References
- Bocchino M, Marruchella A, Saltini C. Immunogenetics of severe respiratory infections: models for the development of new therapeutic strategies. Respiration 2005;72:449–457
- Berenbaum F. Pro-inflammatory cytokines, prostaglandins, and the chondrocyte: mechanisms of intracellular activation. Joint Bone Spine 2000;67:561–564
- Tousoulis D, Charakida M, Stefanadis C. Endothelial function and inflammation in coronary artery disease. Heart 2005;92:441–444
- Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117:1175–1183
- Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107:7–11
- Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 1998;11:1218–1221
- Sriskantharajah S, Hamblin N, Worsley S, Calver AR, Hessel EM, Amour A. Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases. Ann N Y Acad Sci 2013;1280:35–39
- O'keefe JH, Gheewala NM, O'keefe JO. Dietary strategies for improving postprandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008;51:249–255
- Shin IS, Lee MY, Lim HS, et al. An extract of Crataegus pinnatifida fruit attenuates airway inflammation by modulation of matrix metalloproteinase-9 in ovalbumin induced asthma. PLoS One 2012;7:e45734
- Lin CH, Yeh CH, Lin LJ, et al. The Chinese herbal medicine formula Sheng-Fei-Yu-Chuan-Tang suppresses Th2 responses and increases IFN γ in Dermatophagoides pteronyssinus induced chronic asthmatic mice. Evid Based Complement Alternat Med 2013;2013:984121
- Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685–1693
- Rochelle LG, Fischer BM, Adler KB. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radical Biol Med 1998;24:863–868
- Rahman I. Oxidative stress, transcription factors and chromatin remodeling in lung inflammation. Biochem Pharmacol 2002;64:935–942
- Kim HJ, Lee HS, Chong YH, Kang JL. p38 mitogen-activated protein kinase up-regulates LPS-induced NF-κB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 2006;225:36–47
- Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225–260
- Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141–179
- Karin M, Delhase M. The Ikappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin Immunol 2000;12:85–98
- Pearson G, Robinson F, Gibson TB, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153–183
- Ajizian SJ, English BK, Meals EA. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferongamma. J Infect Dis 1999;179:939–944
- Saccani S, Pantano S, Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 2002;3:69–75
- Kong FH, Zhu DY, Xu RS. Structural study of tubeimoside I, a constituent of tu-bei-mu. Tetrahedron Lett 1986;27:5765–5768
- Zhao XM. Supplement to the compendium of materia medica. Beijing: 1765 wood-engraved edition in Chinese language; 1983:123–124
- Yu LJ, Ma RD, Wang YQ. Potent anti-tumorigenic effect of tubeimoside 1 isolated from the bulb of Bolbostemma paniculatum (Maxim) Franquet. Int J Cancer 1992;50:635–638
- Yu L, Ma R, Wang Y, Nishino H. Potent anti-tumor activity and low toxicity of tubeimoside 1 isolated from Bolbostemma paniculatum. Planta Med 1994;60:204–208
- Huang P, Yu C, Liu XQ, et al. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway. Int J Mol Med 2011;28:579–587
- Parsey MV, Tuder RM, Abraham E. Neutrophils are major contributors to intraparenchymal lung IL-1b expression after hemorrhage and endotoxemia. J Immunol 1998;160:1007–1013
- Fitzpatrick M, Young SP. Metabolomics – a novel window into inflammatory disease. Swiss Med Wkly 2013;21:143–13743
- Kim KR, Son EW, Rhee DK, Pyo S. The immunomodulatory effects of the herbicide simazine on murine macrophage functions in vitro. Toxicol In Vitro 2002;16:517–523
- Yang J, Qu JM, Summah H, et al. Protective effects of imipramine in murine endotoxin-induced acute lung injury. Eur J Pharmacol 2010;638:128–33
- Rubenfeld GD. Epidemiology of acute lung injury. Crit Care Med 2003;31:S276–S284
- Zhang XM, Song KJ, Xiong HZ, et al. Protective effect of florfenicol on acute lung injury induced by lipopolysaccharid in mice. Int Immunopharmacol 2009;9:1525–1529
- Joshua AS, Arabinda D, Swapan KR, Naren LB. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012;87:10–20
- Lin Y, Zhu X, Yao WZ, et al. Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats. Chin Med J 2011;124:1069–1074
- Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145–156
- Giebelen IA, van Westerloo DJ, LaRosa GJ, et al. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 2007;28:700–703
- Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005;41:2502–2512
- Martin TR. Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest 1999;116:2S–8S
- Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS. Chest 1995;108:1303–1314
- Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523–535
- Mecklenburgh K, Murray J, Brazil T, et al. Role of neutrophil apoptosis in the resolution of pulmonary inflammation. Monaldi Arch Chest Dis 1999;54:345–349
- Cavailllon JM, Adib-Conquy M. Monocytes/macrophages and sepsis. Crit Care Med 2005;33:S506–S509
- Johansson MW, Patarroyo M, Oberg F, et al. Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). J Cell Sci 1997;110:1133–1139
- Zhang XZ, Li JH, Chen C, et al. Protective effect of abamectin on acute lung injury induced by lipopolysaccharide in mice. Fundam Clin Pharmacol 2010;25:700–707
- Chu X, Ci XX, Wei MM, et al. Licochalcone A Inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J Agric Food Chem 2012;60:3947–3954
- Baldwin AS. The NF-kappaB and I kappa-B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649–683
- Baeuerle PA. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 1998;95:729–731
- Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680–6684
- Tanaka T, Grusby MJ, Kaisho T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 2007;8:584–591
- Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101–3109
- Kaisho T, Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 2002;1589:1–13
- Liaudet L, Rosselet A, Schaller MD, et al. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 1998;177:127–132
- Yang J, Murphy C, Denham W, et al. Evidence of a central role for p38 map kinase induction of tumor necrosis factor alpha in pancreatitis-associated pulmonary injury. Surgery 1999;126:216–222
- Haddad EB, Birrell M, McCluskie K, et al. Role of p38 MAP kinase in LPS-induced airway inflammation in the rat. Br J Pharmacol 2001;132:1715–1724
- Nash SP, Heuertz RM. Blockade of p38 map kinase inhibits complement induced acute lung injury in a murine model. Int Immunopharmacol 2005;5:1870–1878
- Lee JC, Young PR. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukocyte Biol 1996;59:152–157
- Carter AB, Knudtson KL, Monick MM, Hunninghake GW. The p38 mitogen activated protein kinase is required for NFkappaB-dependent gene expression: the role of TATA-binding protein (TBP). J Biol Chem 1999;274:30858–30863
- Yoshinari D, Takeyoshi I, Koibuchi Y, et al. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001;29:628–634
- Schuh K, Pahl A. Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury. Biochem Pharmacol 2009;77:1827–1834
- Bruggen T, Nijenhuis S, van Raaij E, et al. Lipopolysaccharide-induced tumor necrosis factor α production by human monocytes involves the raf-1/MEK1–MEK2/ERK1–ERK2 pathway. Infect Immun 1999;67:3824–3829
- Means TK, Pavlovich RP, Roca D, et al. Activation of TNF-α transcription utilizes distinct MAP kinase pathways in different macrophage populations. J Leukocyte Biol 2000;67:885–893
- Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 1999;20:751–758
- Soromou LW, Chen N, Jiang L, et al. Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway. Biochem Biophys Res Commun 2012;419:256–261
- Bai GZ, Yu HT, Ni YF, et al. Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice. J Surg Res 2012;182:303--11
- Soromou LW, Chu X, Jiang L, et al. In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. Int Immunopharmacol 2012;14:66–74